What is the current price / NAV of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The current NAV of HDFC Pharma and Healthcare Fund(IDCW Reinvest) is ₹15.32, as of 10th March 2025.What are the returns of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The HDFC Pharma and Healthcare Fund(IDCW Reinvest) was launched on 4th October 2023. This mutual fund's past returns are as follows:- 1 Year Returns: 24.41%
What are the top 5 sectoral holdings of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The top sectors HDFC Pharma and Healthcare Fund(IDCW Reinvest) has invested in are as follows:- Pharmaceuticals | 75.21%
- Labs & Life Sciences Services | 21.21%
- Health Care Equipment & Supplies | 1.49%
- Miscellaneous | 1.13%
- Others | 0.96%
What are the top 5 holdings of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The top 5 holdings for HDFC Pharma and Healthcare Fund(IDCW Reinvest) are as follows:- Sun Pharmaceutical Industries Ltd | 11.99%
- Divi's Laboratories Ltd | 8.91%
- Cipla Ltd | 7.80%
- Lupin Ltd | 5.57%
- Max Healthcare Institute Ltd | 4.87%
What is the asset allocation of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The asset allocation for HDFC Pharma and Healthcare Fund(IDCW Reinvest) is as follows:- Equity | 99.05%
- Cash & Equivalents | 0.95%
What is the AUM of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The AUM (i.e. assets under management) of HDFC Pharma and Healthcare Fund(IDCW Reinvest) is ₹1468.68 Cr as of 10th March 2025.What is the expense ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The expense ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest) Plan is 0.97 as of 10th March 2025.What is the alpha ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The alpha ratio for the HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 4.60
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The volatility or standard deviation for the HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 15.56
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The Sharpe ratio for the HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 1.33
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The Sortino Ratio for the HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 0.14
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest)?
The PE ratio of HDFC Pharma and Healthcare Fund(IDCW Reinvest) is 43.86, while category PE ratio is 45.92.
Add to Watchlist
Share
How to use scorecard? Learn more
HDFC Pharma and Healthcare Fund(IDCW Reinvest)
IDCW
EquitySectoral Fund - Pharma & Health Care
Mid-size FundAssets Under Mgmt: ₹ 1,468 Cr
Very High RiskPrinciple investment will be at very high risk
15.320.81% (-0.13)
Price Chart
High
—
Low
—
Returns
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
1M
6M
1Y
3Y
5Y
Max
SIP
How to use scorecard? Learn more
EquitySectoral Fund - Pharma & Health Care
Mid-size FundAssets Under Mgmt: ₹ 1,468 Cr
Very High RiskPrinciple investment will be at very high risk
Key Metrics
| Expense RatioExpense Ratio | No LabelNo Label | No LabelNo Label |
|---|---|---|
| 0.97 | 43.86 | 1.33 |
| No LabelNo Label | No LabelNo Label | No LabelNo Label |
|---|---|---|
| 1.48 | 45.92 | 0.10 |
Scheme Info
| PlanPlan | Lock inLock in | Exit LoadExit Load |
|---|---|---|
| IDCW | 0 yrs | 1.00% |
| SIP Inv.SIP Inv. | Min. LumpsumMin. Lumpsum |
|---|---|
| Allowed | ₹ 100 |
| BenchmarkBenchmark |
|---|
| BSE Health Care - TRI |
About Sectoral Fund - Pharma & Health Care
Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.
Peers & Comparison
Comparing 3 mutual funds from
EquitySectoral Fund - Pharma & Health Care
EquitySectoral Fund - Pharma & Health Care
Returns
Scheme
Ratios
| Mutual Fund | 1Y Returns1Y Returns | 3Y CAGR3Y CAGR | Life CAGRLife CAGR |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund(IDCW Reinvest) | 24.41% | — | 35.02% |
| Nippon India Pharma Fund(IDCW) | 0.98% | 13.70% | 10.09% |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW-Payout) | 7.81% | 13.97% | 14.35% |
| SBI Healthcare Opp Fund(IDCW-Payout) | 17.66% | 23.65% | 16.24% |
Price Comparison
Compare HDFC Pharma and Healthcare Fund(IDCW Reinvest) with any MF, ETF, stock or indexCompare HDFC Pharma and Healthcare Fund(IDCW Reinvest) with any MF, ETF, stock or index
HDFC Pharma and Healthcare Fund(IDCW Reinvest)
Hmm, looks like data is unavailable here. Please come back after some timeAsset Allocation
Actual
Target
Jun 2024
Sep 2024
Dec 2024
Feb 2025
ACTUAL
Jun 2024
Sep 2024
Dec 2024
Feb 2025
Sector Distribution
Jun 2024
Sep 2024
Dec 2024
Feb 2025
Sector Weightage
Pharmaceuticals
Pharmaceuticals as a % of total holdings for last six quarters
Current Holdings
Equity
Others
- ConstituentHolding Weight3M Change
Holdings
11.99 %
-1.50 %Holdings
8.91 %
1.07 %Holdings
7.80 %
0.06 %
AMC Profile
HDFC Asset Management Company, investment manager to HDFC Mutual Fund, is one of the leading AMCs in the country. The company operates as a joint venture between Housing Development Finance Corporation (HDFC) and Standard Life Investments (SLI).
No.of Schemes
84
Total AUM
₹ 7,30,257.80 Cr.
Fund Manager Profile
Nikhil Mathur
AUM: ₹1,468.68 Cr.
|
Exp: 7yrs
Qualification
PGDM - IMT, B.E. (Civil), CFA (USA)
Past Experience
Over 7 years of experience in equity research and 2 years in financial advisory.
Funds Managed (4)
Equity (4)
22.87%
—
2.13%
24.41%
—
0.97%
22.87%
—
2.13%
24.41%
—
0.97%
Manager Performance (0)
Equity: Sectoral Fund - Pharma & Health Care
Tax Implications
Let’s calculate your returns after tax
Investment frequency
Monthly
One Time
Monthly Investment Amt. (₹)
Investment period (years)
CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.
Historical
+
-
You make
Opinions and Fund Reviews
The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.
Invested period < 1 year
Gains are treated as short-term capital gains and taxed at 20%
Invested period > 1 year
Gains are treated as long-term capital gains and taxed at 12.5%